Prevalence of SXT/R391-like integrative and conjugative elements carrying blaC MY-2 in Proteus mirabilis

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 10, 2011, Pages 2266-2270

  Mata, Caterina ^a   Navarro, Ferran ^a   Miró, Elisenda ^a   Walsh, Timothy R ^b   Mirelis, Beatriz ^a   Toleman, Mark ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

AmpC lactamases; Enterobacteriaceae; Mobile genetic elements

Indexed keywords

ANTITOXIN; BACTERIAL PROTEIN; BETA LACTAMASE AMPC; BETA LACTAMASE CMY 2; BETA LACTAMASE CTX M; CARBAPENEMASE; EXTENDED SPECTRUM BETA LACTAMASE; INTEGRASE; R391 INTEGRATIVE CONJUGATIVE ELEMENTS; SXT INTEGRATIVE CONJUGATIVE ELEMENT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; GENETIC ORGANIZATION; HYBRIDIZATION; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PROTEUS MIRABILIS; SOUTHERN BLOTTING;

BACTERIAL PROTEINS; BETA-LACTAMASES; CONJUGATION, GENETIC; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INTEGRASES; INTERSPERSED REPETITIVE SEQUENCES; MICROBIAL SENSITIVITY TESTS; PLASMIDS; PROTEUS INFECTIONS; PROTEUS MIRABILIS;

EID: 79960963278     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr286     Document Type: Article

References (14)

1. Aragón L, Mirelis B, Miró E et al. Increase in β-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type β-lactamases. J Antimicrob Chemother 2008; 61: 1029-32.
2. Endimiani A, Luzzaro F, Brigante G et al. Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum β-lactamases. Antimicrob Agents Chemother 2005; 49: 2598-605.
3. Mata C, Miró E, Rivera A et al. Prevalence of acquired AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007. Clin Microbiol Infect 2010; 16: 472-6.
4. Jacoby G. AmpC β-lactamases. Clin Microbiol Rev 2009; 22: 161-82.
5. CMY-2-like genes in Enterobacteriaceae. Antimicrob Agents Chemother 2009; 53: 4002-6.
6. CMY-2 located on a novel SXT/R391-related integrating conjugative element in a Proteus mirabilis clinical isolate. Antimicrob Agents Chemother 2010; 54: 3545-50.
7. Wozniak RA, Waldor MK. Integrative and conjugative elements: mosaic mobile genetic elements enabling dynamic lateral gene flow. Nat Rev Microbiol 2010; 8: 552-63.
8. Burrus V, Waldor MK. Formation of SXT tandem arrays and SXT-R391 hybrids. J Bacteriol 2004; 186: 2636-45.
9. DHA-1 and qnrB genes between Escherichia coli and Serratia marcescens. FEMS Microbiol Lett 2010; 308: 24-8.
10. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100-S19. CLSI, Wayne, PA, USA, 2009.
11. García-Fernández A, Fortini D, Veldman K et al. Characterization of plasmids harbouring qnrS1, qnrB2 and qnrB19 genes in Salmonella. J Antimicrob Chemother 2009; 63: 274-81.
12. Carattoli A, Bertini A, Villa L et al. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005; 63: 219-28.
13. Liu S, Hessel A, Sanderson K. Genomic mapping with I-Ceu I, an intron-encoded endonuclease specific for genes for ribosomal RNA, in Salmonella spp., Escherichia coli, and other bacteria. Proc Natl Acad Sci USA 1993; 15: 6874-8.
14. D'Andrea MM, Literacka E, Zioga A et al. Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe. Antimicrob Agents Chemother 2011; 55: 2735-42.